Ankur Dhingra - Net Worth and Insider Trading

Ankur Dhingra Net Worth

The estimated net worth of Ankur Dhingra is at least $2 Million dollars as of 2024-05-28. Ankur Dhingra is the CFO of Summit Therapeutics Inc and owns about 354,958 shares of Summit Therapeutics Inc (SMMT) stock worth over $1 Million. Ankur Dhingra is also the CFO of CareDx Inc and owns about 19,500 shares of CareDx Inc (CDNA) stock worth over $310,830. Details can be seen in Ankur Dhingra's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ankur Dhingra has not made any transactions after 2024-03-26 and currently still holds the listed stock(s).

Transaction Summary of Ankur Dhingra

To

Ankur Dhingra Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ankur Dhingra owns 2 companies in total, including CareDx Inc (CDNA) , and Summit Therapeutics Inc (SMMT) .

Click here to see the complete history of Ankur Dhingra’s form 4 insider trades.

Insider Ownership Summary of Ankur Dhingra

Ticker Comapny Transaction Date Type of Owner
CDNA CareDx Inc 2021-11-24 Chief Financial Officer
SMMT Summit Therapeutics Inc 2024-03-26 Chief Financial Officer

Ankur Dhingra Latest Holdings Summary

Ankur Dhingra currently owns a total of 2 stocks. Among these stocks, Ankur Dhingra owns 354,958 shares of Summit Therapeutics Inc (SMMT) as of March 26, 2024, with a value of $1 Million and a weighting of 79.42%. Ankur Dhingra also owns 19,500 shares of CareDx Inc (CDNA) as of November 24, 2021, with a value of $310,830 and a weighting of 20.58%.

Latest Holdings of Ankur Dhingra

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SMMT Summit Therapeutics Inc 2024-03-26 354,958 3.38 1,199,758
CDNA CareDx Inc 2021-11-24 19,500 15.94 310,830

Holding Weightings of Ankur Dhingra


Ankur Dhingra Form 4 Trading Tracker

According to the SEC Form 4 filings, Ankur Dhingra has made a total of 5 transactions in Summit Therapeutics Inc (SMMT) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Summit Therapeutics Inc is the acquisition of 100,000 shares on March 26, 2024, which cost Ankur Dhingra around $375,000.

According to the SEC Form 4 filings, Ankur Dhingra has made a total of 1 transactions in CareDx Inc (CDNA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in CareDx Inc is the acquisition of 5,000 shares on November 24, 2021, which cost Ankur Dhingra around $211,700.

Insider Trading History of Ankur Dhingra

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ankur Dhingra Trading Performance

GuruFocus tracks the stock performance after each of Ankur Dhingra's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ankur Dhingra is 25.14%. GuruFocus also compares Ankur Dhingra's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ankur Dhingra within 3 months outperforms 4 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ankur Dhingra's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ankur Dhingra

Average Return

Average return per transaction

Outperforming Transactions

3 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 17.35
Relative Return to S&P 500(%) 20.17

Ankur Dhingra Ownership Network

Ownership Network List of Ankur Dhingra

No Data

Ownership Network Relation of Ankur Dhingra


Ankur Dhingra Owned Company Details

What does CareDx Inc do?

Who are the key executives at CareDx Inc?

Ankur Dhingra is the Chief Financial Officer of CareDx Inc. Other key executives at CareDx Inc include See Remarks Reginald Seeto , director & President and CEO Peter Maag , and See Remarks Abraham Ronai .

CareDx Inc (CDNA) Insider Trades Summary

Over the past 18 months, Ankur Dhingra made no insider transaction in CareDx Inc (CDNA). Other recent insider transactions involving CareDx Inc (CDNA) include a net sale of 70,941 shares made by Reginald Seeto , and a net sale of 15,701 shares made by Peter Maag .

In summary, during the past 3 months, insiders sold 0 shares of CareDx Inc (CDNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 86,642 shares of CareDx Inc (CDNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 86,642 shares.

CareDx Inc (CDNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CareDx Inc Insider Transactions

No Available Data

Ankur Dhingra Mailing Address

Above is the net worth, insider trading, and ownership report for Ankur Dhingra. You might contact Ankur Dhingra via mailing address: C/o Caredx, Inc., 1 Tower Place, 9th Floor, South San Francisco Ca 94080.

Discussions on Ankur Dhingra

No discussions yet.